Mulibrey syndrome

MULIBREY syndrome (acronym in English that refers to the main affected organs: (MU) scle, (LI) ver, (BR) ain, and (EY) e; or muscle , liver , brain and eye , respectively) is a growth disorder of prenatal onset with multi-organ manifestations.

Summary

[ hide ]

  • 1 Synonyms
  • 2 Prevalence
  • 3 Inheritance
  • 4 Age of onset or onset
  • 5 Epidemiology
  • 6 Clinical description
  • 7 Etiology
  • 8 Diagnostic methods
    • 1 Differential diagnosis
    • 2 Prenatal diagnosis
  • 9 Genetic advice
  • 10 Management and treatment
  • 11 Sources

Synonyms

  • MULIBREY dwarfism
  • Perheentupa syndrome

Prevalence

  • Unknown

Heritage

  • Autosomal recessive

Age of onset or onset

  • Childhood, Neonatal

epidemiology

The exact prevalence is unknown, although 115 cases have been described to date.

Clinical description

The syndrome Nanism deficit characterized by pre- and postnatal growth the. Its diagnosis should be considered in newborns with low height for gestational age and subsequent growth deficit in height and weight. Other major diagnostic signs are the characteristic long thin bones with thick cortex and narrow medullary channels, or the J-shaped sella on X-rays . Characteristic craniofacial features are scaphocephaly, triangular face, high and broad forehead, low nasal bridge, and yellowish pigmentation in the middle peripheral region of the retina.. Minor diagnostic signs include a peculiar high-pitched voice, hepatomegaly, cutaneous flaming nevi, and fibrous dysplasia of the long bones. Three main signs or two main signs with three minor signs are required for diagnosis. Psychomotor development is generally normal. Restrictive cardiomyopathy is the most serious manifestation of the disease. Feeding difficulties, pneumonia and recurrent respiratory infections are common problems during childhood. Wilms tumor risk is increased and women are at very high risk of developing ovarian fibrotecomas. Women also have premature ovarian failure and are infertile. Furthermore, the majority of those affected develop severe insulin resistance and syndrome metabolic already at an early age.

Etiology

The syndrome is caused by mutations in the TRIM37 gene that encodes the peroxisomal protein TRIM37 of unknown function. In Finland , a major founder mutation is observed in all patients, four of them being compound heterozygotes for the Finnish major mutation and one of the three minor mutations. Private mutations represent non-Finnish cases. Molecular genetic testing for the detection of mutations in the TRIM37 gene is available in Finland.

Diagnostic methods

Complete sequencing of the TRIM37 gene is necessary in affected non-Finns.

Differential diagnosis

The differential diagnosis includes dysmorphic syndromes with pre- and postnatal growth failure, such as Silver-Russell syndrome and 3M syndrome.

Prenatal diagnosis

Prenatal molecular genetic testing is possible, but limited to families known to be affected by MULIBREY syndrome.

Genetic advice

The syndrome Nanism is an autosomal recessive disorder.

Management and treatment

Early recognition and management of diet , respiratory problems, or cardiac involvement from pericardiectomy are of great importance. Growth hormone treatment produces good growth results in the short term, but only modest in the long term. From adolescence , it should observe the metabolism of glucose and postpubertal women require regular gynecological follow.

 

Leave a Comment

Scroll to Top